CordenPharma Highly Potent & Oncology Platform

Products

Information

One Source for Highly Potent & Oncological Products Integrated Supply: APIs & Oral / Sterile Drug ProductsState-of-the-art facilities able to handle API and Drug Product of the highest potencyDevelopment, clinical trial and commercial manufacturingFull-service offering including packaging / labeling and distribution n facilities inspected by all major regulatory agencies

Main Categories

Custom ManufacturingFinished Dosage Forms

All Categories

CapsulesCustom ManufacturingCustom Manufacturing of Dosage Form DrugsFinished Dosage FormsTablets

Distribution areas

OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)

Supplied from

United States

Corden Pharma International GmbHCordenPharma is a CDMO partner supporting biotech and pharma innovators of complex modalities in the advancement of their drug development lifecycle. Harnessing the collective expertise of the teams across its globally integrated facility network, CordenPharma provides bespoke outsourcing services spanning the complete supply chain, from early clinical-phase development to commercialization. With scientific expertise and partnership at its core, CordenPharma provides customers high-value, end-to-end services with a strategic focus on Peptides, Oligonucleotides, customized Lipid Excipients, Lipid NanoParticles (LNPs), sterile Injectables, and the extensive supply of Small Molecules (both Highly Potent and Regular Potency). The CordenPharma Group is comprised of 12 facilities across Europe and North America. In the 2022 financial year, the organization generated sales of 870 million Euros and had over 3,000 employees. Please visit cordenpharma.com for more information.

CordenPharma Highly Potent & Oncology Platform

Information

Log in